Your session is about to expire
← Back to Search
Behavioral Intervention
Culturally tailored HLWD for Diabetes
N/A
Recruiting
Led By Olayinka Shiyanbola, PhD, BPharm
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 6 months
Awards & highlights
Study Summary
This trial aims to run a program called Healthy Living with Diabetes for Black individuals in a way that respects their culture. About 24-30 people will take part and the study will last for around
Who is the study for?
This trial is for Black individuals who self-identify as such and have any form of diabetes, including type 1, type 2, gestational, or pre-diabetes. The study will include a small group of about 24-30 participants.Check my eligibility
What is being tested?
The study tests the Healthy Living with Diabetes (HLWD) program that's been tailored to be culturally appropriate for the participants. It's designed to last around six months.See study design
What are the potential side effects?
Since this is a lifestyle intervention program rather than a drug trial, traditional side effects are not expected. However, changes in diet and exercise may lead to discomfort or require an adjustment period.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 weeks, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Recruitment: Number of HLWD Participants Enrolled in a HLWD Workshop vs Invited to Enroll
Recruitment: Number of Miles Participants are Willing to Travel for a Workshop
Retention Rate during a 6-week Session
+4 moreSecondary outcome measures
Effectiveness: Diabetes Empowerment Scale - Short Form Self-Efficacy for Adherence to Medication Use Scale
Effectiveness: Patient's Perceived Involvement in Care Scale (PICS)
Effectiveness: Self-Reported Health Status
+6 moreOther outcome measures
Beliefs about Medicines Questionnaire (BMQ)
Brief Illness Perception Questionnaire (B-IPQ)
Diabetes Distress Scale (DDS-2)
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Culturally tailored HLWDExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,190 Previous Clinical Trials
3,169,597 Total Patients Enrolled
6 Trials studying Diabetes
515 Patients Enrolled for Diabetes
UW Institute of Clinical and Translational ResearchUNKNOWN
Olayinka Shiyanbola, PhD, BPharmPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
407 Total Patients Enrolled
1 Trials studying Diabetes
376 Patients Enrolled for Diabetes
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment phase of this clinical trial still ongoing?
"Based on information from clinicaltrials.gov, this research endeavor is actively seeking participants. The trial was initially published on March 1st, 2024 and last revised on March 25th, 2024."
Answered by AI
What is the total number of participants being selected for enrollment in this clinical trial?
"Indeed, data from clinicaltrials.gov confirms that this investigation is actively seeking participants. The study was initially published on March 1st, 2024 and the most recent update occurred on March 25th, 2024. There is a need to recruit 30 individuals across two distinct sites for this trial."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger